ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 132 filers reported holding ENDOLOGIX INC in Q1 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $547,000 | -81.0% | 75,500 | -85.0% | 0.16% | -84.7% |
Q4 2016 | $2,886,000 | +13.0% | 504,600 | +146.1% | 1.06% | -2.5% |
Q2 2016 | $2,554,000 | -30.0% | 205,000 | -53.0% | 1.09% | -34.5% |
Q1 2016 | $3,646,000 | +36.4% | 436,100 | +61.5% | 1.66% | +47.0% |
Q4 2015 | $2,673,000 | +6.3% | 270,000 | +31.6% | 1.13% | -21.4% |
Q3 2015 | $2,515,000 | – | 205,100 | – | 1.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Capital Management, LLC | 4,050,000 | $62,127,000 | 7.14% |
Essex Woodlands Management, Inc. | 1,257,468 | $24,875,000 | 4.49% |
First Light Asset Management, LLC | 304,602 | $4,673,000 | 2.20% |
ArrowMark Colorado Holdings LLC | 3,464,775 | $53,150,000 | 1.30% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,449,897 | $37,581,000 | 1.25% |
Iguana Healthcare Management, LLC | 200,000 | $3,068,000 | 0.97% |
WASHINGTON CAPITAL MANAGEMENT, INC | 82,316 | $1,262,000 | 0.71% |
PALISADE CAPITAL MANAGEMENT, LP | 1,651,798 | $25,339,000 | 0.64% |
PERKINS CAPITAL MANAGEMENT INC | 34,200 | $525,000 | 0.46% |
CADIAN CAPITAL MANAGEMENT, LP | 967,443 | $14,841,000 | 0.44% |